Abstract
Histone deacetylase enzymes (HDACs) are potential targets for the treatment of cancer and other diseases, but it is challenging to design isoform-selective agents. In this work, we created new analogs of two established but non-selective HDAC inhibitors. We decorated the central linker chains of the molecules with specifically positioned fluorine atoms in order to control the molecular conformations. The fluorinated analogs were screened against a panel of 11 HDAC isoforms, and minor differences in isoform selectivity patterns were observed.
| Original language | English |
|---|---|
| Article number | 3974 |
| Pages (from-to) | 1-17 |
| Number of pages | 17 |
| Journal | Molecules |
| Volume | 26 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 29 Jun 2021 |
| Externally published | Yes |
Bibliographical note
Copyright the Author(s) 2021. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.Keywords
- SAHA
- Scriptaid
- stereoselective fluorination
- HDAC
- Stereoselective fluorination